ArticleBlood2017
Open access · bronzeAbstract readVideo-Audio Media
In one paragraph
Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 54 citations in OpenAlex.
- A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP-ALL uncovers novel therapeutic targets.HemaSphere · 2026Article
- The miRNA Landscape of Leukemia - Cellular Actions to Therapy through Molecular Mechanisms.Cell biochemistry and biophysics · 2025Review
- Recent advances in drug delivery and treatment strategies for acute myeloid leukemia.International journal of pharmaceutics · 2025Review
- Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia.Fundamental research · 2025Review
- High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression.Open medicine (Warsaw, Poland) · 2024Article
- Ten-Eleven-Translocation Genes in Cancer.Cancer treatment and research · 2023Review
- Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.Frontiers in immunology · 2023Review
- Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia.Frontiers in genetics · 2023Article
- CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia.Cell proliferation · 2022Article
- Review
- Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm.Cancers · 2021Article
- Knockdown of circ_0001883 may inhibit epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-125-5p/PI3K/AKT axis.Experimental and therapeutic medicine · 2021Article
- Article
- MiR-125b inhibits cardiomyocyte apoptosis by targeting BAK1 in heart failure.Molecular medicine (Cambridge, Mass.) · 2021Article
- HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression.Human genomics · 2021Article
- 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING.The EMBO journal · 2021Article
- The Potential Equivalents ofCancers · 2021Review
- Hyperleukocytic Acute Leukemia Circulating Exosomes Regulate HSCs and BM-MSCs.Journal of healthcare engineering · 2021Article
- Review
- Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.Cancer biomarkers : section A of Disease markers · 2020Article
Corrections and comments
- Commented on by
Authors and funding
14 authors at 4 institutions in 2 countries.
Jun LiuDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Bo GuoDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Zhuo ChenDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Nayi WangDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Michelina IacovinoDepartment of Cell Biology, and.
Jijun ChengDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Christine RodenDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Wen PanDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Sajid KhanDepartment of Surgery, Yale University School of Medicine, New Haven, CT.
Suning ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Michael KybaLillehei Heart Institute and Department of Pediatrics, University of Minnesota, Minneapolis, MN; and.
Rong FanYale Stem Cell Center, Yale Cancer Center, New Haven, CT.
Shangqin GuoYale Stem Cell Center, Yale Cancer Center, New Haven, CT.
Jun LuDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Yale University · USYale Cancer Center · USFirst Affiliated Hospital of Soochow University · CNUniversity of Minnesota · US
Funding
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0MGENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2MMolecular definition of cancer cell-of-originDP2GM123507 · NIGMS · YALE UNIVERSITY · PI GUO, SHANGQIN · 2016 to 2016
$2.5MNovel Approaches to Mammalian MicroRNA Target PredictionR01GM099811 · NIGMS · WADSWORTH CENTER · PI DING, YE, LU, JUN · 2012 to 2015
$2.4MThe role of microRNAs in leukemic initiation and maintenanceR01CA149109 · NCI · YALE UNIVERSITY · PI LU, JUN · 2011 to 2015
$1.7MNCI NIH HHS P30 CA016359NCI NIH HHS R01 CA149109NICHD NIH HHS T32 HD007149NIGMS NIH HHS DP2 GM123507NIGMS NIH HHS R01 GM099811
Abstract
The hematopoietic stem cell-enriched
Indexed as
AnimalsApoptosisCell ProliferationGene Expression Regulation, LeukemicGene Knock-In TechniquesHematopoiesisHematopoietic Stem CellsLeukemia, Myeloid, AcuteMiceMicroRNAsMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionVascular Endothelial Growth Factor AMicroRNAsMirn125 microRNA, mouseMLL-AF9 fusion protein, mouseMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.